Chief Executive Officer
Mr. Connelly joined NeuPath as General Manager in July 2018 and was promoted to Chief Executive Officer on February 1, 2019. Mr. Connelly brings several years of experience in the healthcare field, including with: NeuPath as General Manager; as CEO of VroomHealth Inc.; and as CFO of Appletree Medical Group Inc., a company that operates over 30 primary care clinics and an OntarioMD certified EMR developer; and with an Ontario-based healthcare start-up. Throughout his career, Mr. Connelly has played a leadership role in closing M&A transactions valued at over $200 million. Mr. Connelly holds a Master of Business Administration degree from the Schulich School of Business at York University, and a Bachelor of Accounting from Brock University.
Chief Financial Officer and Corporate Secretary
Mr. Lemieux joined NeuPath as CFO in April 2019. Mr. Lemieux has more than 17 years of experience in public companies including over 8 years as a Chief Financial Officer and 13 years in the health care industry. Mr. Lemieux has been involved with or led numerous debt and equity financings, licensing and M&A transactions valued at over $400 million. Prior to NeuPath, Mr. Lemieux served as the CFO and Secretary at Cipher Pharmaceuticals (TSX:CPH) from 2016 and 2019 and acted as Interim-CEO from November 2016 to April 2017. Prior to Cipher Pharmaceuticals, Mr. Lemieux was CFO at Nuvo Pharmaceuticals (TSX:NRI) and Crescita Therapeutics (TSX:CTX). Crescita was created on March 1, 2016 by way of a plan of arrangement that reorganized Nuvo Research Inc. into Nuvo and Crescita. Mr. Lemieux is a Chartered Professional Accountant and holds a Master of Management & Professional Accounting degree from the University of Toronto.